| MRSH |
Report |
Marsh organic growth |
BEAT |
pred ~3.8% vs. cons 3.55% |
MEDIUM |
| MRSH |
Report |
Total revenue |
IN-LINE |
pred ~$7.31B vs. cons $7.276B |
MEDIUM |
| MRSH |
Report |
Adjusted EPS |
IN-LINE |
pred ~$2.90 vs. cons $2.888 |
MEDIUM |
| MRSH |
Guide |
Forward organic-growth / pricing commentary (2H26) |
UNKNOWN |
no formal guide; predict stable, mixed pricing tone |
LOW |
| MRSH |
Return |
Day-1 residual (stock − beta × S&P 500) |
-2.0% |
— |
LOW |
| MRSH |
Return |
5-day cumulative residual |
-3.0% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — modest estimate/multiple de-risking |
LOW |